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Abstract
Salmonid alphavirus (SAV) is the causative agent of pancreas disease (PD) in farmed Atlan-
tic salmon. A previous study showed that vaccination of pre-smolt salmon with a plasmid
encoding the structural polypeptide of SAV gave protection against infection and develop-
ment of PD accompanied by production of antibodies against the virus. In the present work
we analyzed transcript responses in the muscle to vaccination with this plasmid (here
named pSAV). The purpose was to shed light on how pSAV might initiate adaptive immune
responses in the fish. The work was based on microarray and reverse transcription quantita-
tive PCR analyses of muscle at the injection site 7 days after vaccination. The results
showed that pSAV and pcDNA3.3 had similar abilities to up-regulate type I IFN stimulated
genes. In contrast, pSAV caused higher up-regulation of IFNγ and several IFNγ inducible
genes. Compared to pcDNA3.3, pSAV also gave larger increase in transcripts of marker
genes for B-cells, T-cells and antigen presenting cells (APCs), which suggest attraction and
role of these cells in the adaptive immune responses elicited by pSAV. Moreover, pSAV
caused a stronger up-regulation of the chemokine CXCL10 and the proinflammatory cyto-
kines IL-1ß and TNFα, which may explain attraction of lymphocytes and APCs. The present
work shows that the expression profile of genes resulting from vaccination with pSAV is dif-
ferent from the expression profiles obtained previously by vaccination of salmonids with
DNA vaccines against infectious salmon anemia virus and infectious hematopoietic necrosis
virus.
Introduction
Virus diseases cause major problems in fish farming due to economic losses and suffering of
infected fish. Traditional vaccines based on inactivated virus have so far been unable to provide
sufficient protection against virus diseases of fish. DNA vaccination against virus has received
high expectations due to the high level of protection obtained with the DNA vaccine against
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infectious hematopoietic necrosis virus (IHN) in salmonids [1–3]. More recently, a DNA vac-
cine against infectious salmon anemia virus (ISAV) has shown a high level of protection when
injected together with a plasmid encoding type I IFN from Atlantic salmon [4]. The vaccine was a
plasmid expressing the virus surface protein hemagglutininesterase (HE) and the IFN plasmid
was shown to function as an adjuvant. A transcriptome analysis of genes induced at the muscle
injection site by a plasmid encoding HE, plasmid vector without insert, and plasmid encoding
IFNa was recently carried out [5]. The work showed that plasmid DNA induced a similar set of
genes as the IFNa plasmid, but at a lower level. In contrast, the HE-plasmid induced lower levels
of IFN-induced genes compared to plasmid without insert. This suggested that HE expressed by
the plasmid, inhibited expression of IFN-induced genes thus explaining the need for IFNa plasmid
as adjuvant. Salmonid alphavirus (SAV) is the causative agent of pancreas disease (PD) in farmed
Atlantic salmon. A DNA vaccine against SAV was recently shown to give significantly higher pro-
tection of Atlantic salmon against pancreas disease (PD) than a commercial vaccine based on
inactivated virus [6]. This vaccine is a plasmid encoding the structural polyprotein C-E3-E2-
6K-E2 of SAV3 (here named pSAV), which upon uptake in cells results in expression of E2 on the
surface of the cells. In contrast to the ISAV DNA vaccine, the SAV3 DNA vaccine did not need
addition of IFN plasmid to achieve protection. In the present study we did transcriptome analyses
of muscle at the injection site of pSAV, pcDNA3.3 and PBS 7 days after injection. This was per-
formed by microarray analysis and reverse transcription quantitative PCR (RT-qPCR).
The purpose of the study was to find out whether expression of the structural proteins of SAV3
have unique effects on gene transcription that might shed light on how this DNA vaccine influ-
ences the immune system. It is likely that the adaptive immune system reacts to antigens as soon
as they are expressed. Day 7 post injection was thus chosen as time point for harvest of mRNA
since it represents early high level expression of plasmid encoded genes in the muscle [5, 7, 8].
The data showed that vaccination with pSAV and the vector plasmid pcDNA3.3 gave simi-
lar up-regulation of type I IFN stimulated genes (ISGs), which is different from the HE-plas-
mid of SAV. In contrast, pSAV caused higher up-regulation of IFNγ and several IFNγ
inducible genes compared to pcDNA3.3. Moreover, pSAV gave increase in transcripts of B-
cells, T-cells and antigen-presenting cells (APCs) presumably due to attraction of these cells by
up-regulation of inflammatory chemokines and cytokines.
Materials and methods
Ethics statement
All fish experiments were approved by the Norwegian Animal Research Authority (NARA)
and Norwegian “Regulation on Animal Experimentation” was observed during fish handling.
Fish
Atlantic salmon (Salmo salar L.) presmolts (30–40 g), Aquagen standard (Aquagen, Kyrksæ-
terøra, Norway), were kept at 10˚C in 300 L tanks supplied with fresh water and were fed com-
mercial dry food in Tromsø Aquaculture Research Station, Norway. For vaccination, fish were
anesthetized with 0.005% benzocaine (ACD Pharmaceuticals, Norway). Different groups of
fish were labeled by tattooing (2% alcian blue, Panjet inoculator). For harvest of muscle sam-
ples, fish were euthanized by an overdose of benzocaine (0.01%).
Treatment of fish with plasmids
pcDNA3.3 encoding the open reading frame (ORF) for SAV3 complete structural polyprotein C-
E3-E2-6K-E1 (pSAV) is based on the genome sequence of the SAV3 H10 isolate (GenBank
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Accession number: JQ799139) and has previously been named pCSP [6]. pcDNA3.3 without insert
was used as control. The plasmids were purified by EndoFree plasmid purification kit from Qiagen.
Presmolt salmon were injected intramuscularly (i.m.) approximately 1 cm below the dorsal fin with
15 μg of plasmid in 50 μl sterile PBS pH 7.4 or with 50 μl PBS only. Fish groups (N = 5) were
injected with PBS (Group 1), pcDNA3.3 (Group 2) and pSAV (Group 3). Muscle samples from the
injection site were harvested one week post injection and used for RNA isolation.
Reverse transcription quantitative PCR (RT-qPCR)
Muscle samples from the injection site were homogenized using TissueLyser II (QIAGEN) (30
sec, 30 1/s) and total RNA was extracted using the RNeasy1 Mini Kit (Qiagen). cDNA was pro-
duced using high capacity cDNA Reverse Transcription kit (Applied Biosystems) (500 ng RNA in
a 20 μl reaction). cDNA was diluted 10 times and 5 μl of cDNA was used per 20 μl PCR reaction,
which also included primers for target gene (0.25 μM) and Fast SYBR1 Green Master Mix
(Applied Biosystems). The samples were applied in duplicates and the measurement was done
using ABI Prism 7500 FAST Cycler from Applied Biosystems (initial denaturation 95˚C: 20s and
40 cycles of 95˚C: 3s, and 60˚C: 30s). Primer sequences are included in S1 Table. Expression val-
ues were normalized against the levels of EF1αβ and fold change in expression of different genes
was calculated against that of PBS group using the method described by Pfaffl [9]. Unpaired t-test
with two-tail distribution was used for statistical analysis, p 0.05.
Microarray analysis
The analyses were carried out essentially as described earlier [5]. Nofima’s Atlantic salmon oli-
gonucleotide microarray SIQ-6 (GEO Accession no. GPL16555) was produced by Agilent
Technologies in the 15 K x 8 format, all reagents and equipment were from the same source
[10]. Analyses included three groups, four individuals per group at one time-point; totally
twelve arrays were used. RNA was isolated as described for RT-qPCR. Total RNA (200 ng per
reaction) was labelled with Cy3 using Low Input Quick Amp Labeling Kit and fragmented
with Gene Expression Hybridization Kit. Hybridization was performed for 17 hours in an
oven at 65˚C at rotation speed of 10 rounds per minute. Arrays were washed for one minute
with Gene Expression Wash Buffer I at room temperature, and one minute with Gene Expres-
sion Wash Buffer II at 37˚C and scanned. Data analyses were carried out with Nofima’s bioin-
formatics package [10]. Global Normalization was performed by equalizing the mean
intensities of all microarrays. Next, the individual values for each feature were divided to the
mean value of all samples producing expression ratios (ER). The log2-ER were calculated and
normalized with the locally weighted non-linear regression (Lowess). The data are presented
as ratios of plasmid injected groups to PBS injected control. Differentially expressed genes
were selected by criteria: p< 0.05 and log2-ER > |0.8| (1.74-fold). The microarray data pre-
sented in this publication has been deposited in the NCBI´s Gene Expression Omnibus (GEO,
https://www.ncbi.nlm.nih.gov/geo/) and is available under the accession number GSE115689.
Results
IFN response
Because type I IFNs (IFN-I) enhance adaptive immune responses and function as adjuvants in
the DNA vaccine against ISAV [4], we wanted to study whether pSAV had any effect on IFN-I
induced genes (ISGs) during DNA vaccination. The microarray data showed that pcDNA3.3 and
pSAV had similar ability to up-regulate typical ISGs such as ISG15, Mx and viperin (Fig 1), which
was confirmed by RT-qPCR (Fig 2A). A similar pattern of response was seen for a several other
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ISGs (Fig 1). In contrast pSAV compared to pcDNA3.3 gave significantly higher up-regulation
of guanylate binding protein 1 (GBP1), interferon regulatory factor 1 (IRF1), IRF5 and IFN-
inducible protein IFI44 (Fig 1). This was confirmed by RT-qPCR for GBP1 and IRF1 (Fig 2B).
Fig 1. Expression of IFN stimulated genes (ISGs) in muscle in response to pcDNA3.3 and pSAV measured by
microarray analysis. The ISGs include the main antiviral genes, interferon regulatory factors (IRFs), virus RNA
sensors and tripartite motif-containing proteins (TRIMS). Groups of fish (N = 4) were injected with PBS, pcDNA3.3
and pSAV. RNA was isolated from muscle at the injection site 7 days post injection. Numbers represent fold changes
compared to the PBS group. Symbols $ and  denote significant difference (p 0.05) between PBS and plasmid
groups, and between pcDNA3.3 and pSAV groups, respectively.
https://doi.org/10.1371/journal.pone.0204924.g001
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GBP-1 is an antiviral and antibacterial GTP-ase while IRF1 activates transcription of IFN-I and
viperin [11–14]. IRF5 is involved in induction of IFN-I, chemokines and proinflammatory cyto-
kines [15–17]. IFI44 has anti-proliferative functions [18]. Notably, GBP1 and IRF1 are more
strongly induced by IFNγ (type II IFN) than by IFN-I in both mammals and Atlantic salmon [19,
20]. Indeed, RT-qPCR showed that pSAV up-regulated IFNγmore strongly than pcDNA3.3 (Fig
2C), which supports that GBP1 and IRF1 were induced by IFNγ in the pSAV group. RT-qPCR
showed that the IFN-I IFNa was slightly up-regulated by pSAV, but not by pcDNA3.3 (Fig 2C).
Attraction of B- and T-cells
Protection of salmon against SAV by vaccination with pSAV, could be due to both increased anti-
body response and increased production of specific cytotoxic T cells. We thus wanted to find out
Fig 2. Expression of type I IFN inducible genes (A), IFNγ inducible genes (B), and type I IFN (IFNa) and type II
IFN (IFNγ) genes (C) in response to vaccination with plasmids. Groups of fish (N = 5) were injected with PBS,
pcDNA3.3 and pSAV. RNA was isolated from muscle at the injection site 7 days post injection and expression of
different IFNs and ISGs was measured by RT-qPCR. Expression value of each gene was normalized against the levels of
EF1αβ. Numbers represents fold increase in expression (mean ± SD) compared to the PBS group. Bars not sharing
common letter indicate significant difference (p 0.05).
https://doi.org/10.1371/journal.pone.0204924.g002
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if pSAV vaccination was associated with increased attraction of B- and T-cells to the muscle injec-
tion site, which should be revealed by gene markers for these cells. The microarray data showed
that both pcDNA3.3 and pSAV enhanced transcripts encoding constant regions of IgD, IgM and
IgT and segments of the heavy and light chains, totally 34 probes (Fig 3), the increase in the pSAV
group was 1.95-fold greater compared to the pcDNA3.3 group. RT-qPCR analysis of membrane
bound IgM (mIgM) and soluble IgM (sIgM) confirmed up-regulation by both plasmids, but only
expression of sIgM was significantly higher in the pSAV group (Fig 4).
The microarray data showed that expression of T-cell receptor (TCR) alpha and beta chains
were increased by both plasmids, but were significantly higher up-regulated by pSAV than by
pcDNA3.3 (Fig 5). This was confirmed by RT-qPCR for TCRbeta (Fig 4). The microarray anal-
ysis also showed that compared to pcDNA3.3, pSAV caused significant higher increase in tran-
scripts for other typical T-cell markers (Fig 5). This was confirmed by RT-qPCR for CD4,
CD8a, CD3z and granzyme K (Fig 4). Taken together these data suggests that B- and T-cells
are attracted to the muscle injection site by plasmid DNA and that pSAV had a stronger attrac-
tive effect than pcDNA3.3, especially on T-cells.
MHC I antigen presentation pathway
Most cells have the ability to present antigen to cytotoxic T-cells through MHC I, which occurs
by digestion of antigen by the proteasome, transportation of peptides into ER by TAP followed
by loading of antigenic peptides onto MHC-I involving tapasin and other chaperone molecules
[21]. As shown in Fig 6, the microarray data showed that pcDNA3.3 and pSAV up-regulated
to a similar extent MHC I, beta-2-microglobulin and PSMB8, which is a subunit of the protea-
some. This was confirmed by RT-qPCR for MHC I (Fig 7A). Other proteasome subunits
(PSMB6B and PSMB7) were significantly higher up-regulated by pSAV than by pcDNA3.3
Fig 3. B cell specific genes, microarray results. Markers correspond to probes representing constant regions of IgM,
IgT and IgD and segments of light and heavy chains (totally 34 probes). Data are log2-ER (expression ratio) to PBS
control. Difference between the groups is significant (p<0.0001, paired t test).
https://doi.org/10.1371/journal.pone.0204924.g003
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(Fig 6). Higher transcript values were also observed for TAP and tapasin in the pSAV group,
but the differences between pSAV and pcDNA3.3 were not significant for these genes. Inter-
estingly, PSMB6, PSMB7, TAP and tapasin are all IFNγ -induced genes [22–25].
Antigen presenting cells (APCs) and the MHC II antigen presentation
pathway
Since attraction of APCs might indicate that antigen presentation to T-cells occurs at the mus-
cle injection site, we analysed expression of genes for surface markers of APCs. Extracellular
protein antigens are taken up by APCs and processed by endolysosomal proteases into pep-
tides, which are loaded onto MHC II molecules by displacing the peptide CLIP derived from
the class II-associated invariant chain, which is also known as MHC II gamma chain or CD74
when it is surface expressed [26]. The microarray data showed that compared to pcDNA3.3,
pSAV up-regulated more strongly MHC II alpha and beta chains and CD74 (Fig 8). RT-qPCR
confirmed stronger up-regulation of MHC II by pSAV (Fig 7A). One of the most prominent
genes that showed higher transcript levels with pSAV was high affinity Ig receptor I (FcγRI),
which is encoded by FCGRI (Figs 7B and 8). This protein is expressed on monocytes, macro-
phages and dendritic cells (DCs) and can be up-regulated by IFNγ [27, 28].
Effector molecules of APCs/phagocytic cells
pSAV showed higher transcript levels of lysozyme G, cytochrome b-245 beta chain and neu-
trophil cytosol factor (NCF1), also known as p47phox (Fig 8). Lysozymes are responsible for
degradation of peptidoglycans in the cell wall of gram-positive and gram-negative bacteria.
NCF1 is the cytoplasmic subunit of NADPH-oxidase complex in neutrophils and macro-
phages. NCF1 has a central role in oxidative burst, which leads to production of superoxide
anion and formation of antimicrobial reactive oxygen species [29]. Cytochrome b-245 is a
Fig 4. Expression of T- and B- cell marker genes in response to injection of plasmids measured by RT-qPCR. Treatment
groups and experimental details as described in Fig 2. Expression value of each gene was normalized against the levels of EF1αβ.
Numbers represents fold increase in expression (mean ± SD) compared to the PBS group. Bars not sharing common letter indicate
significant difference (p 0.05).
https://doi.org/10.1371/journal.pone.0204924.g004
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membrane-bound component of the NADPH-oxidase complex [30]. RT-qPCR confirmed
that NCF1 was significantly higher expressed in response to pSAV compared to pcDNA3.3
and PBS (Fig 7B). Altogether the increase in transcripts of this group of genes suggests attrac-
tion of phagocytic cells like macrophages or neutrophils to the site of pSAV injection.
Other leukocyte markers
Several other genes, which are commonly expressed by lymphocytes and other leukocytes
were significantly higher up-regulated by pSAV than by pcDNA3.3 (S1 Fig). These included
plastin-2, Wiskott-Aldrich syndrome protein (WASP) and Src kinase-associated phosphopro-
tein 2 (Skap-2). Plastin-2 is specifically expressed in hematopoietic cell lineage and has impor-
tant roles in processes related to neutrophil biology and function, stabilization of immune
synapse (IS) between MHCII and TCR, T-cell activity as well as T-cell and B-cell motility and
macrophage activity [31]. WASP is necessary for many lymphoid immune cell functions like
phagocytosis, NK-cell cytotoxicity, TCR/BCR downstream signaling and monocyte chemo-
taxis [32, 33]. Skap-2 is involved in macrophage cytoskeletal rearrangement [34].
Fig 5. Microarray data of T cell marker genes. Data produced and presented as explained in Fig 1.
https://doi.org/10.1371/journal.pone.0204924.g005
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Chemokines and pro-inflammatory cytokines
Attraction of leukocytes to the plasmid injection site must be mediated by chemokines and
proinflammatory cytokines [35]. Microarray data for chemokines, chemokine receptors and
cytokine receptors that showed up-regulation with pcDNA3.3 and pSAV are presented in Fig
9. The data showed higher transcript values for the chemokines CCL4, CCL19 and CXCL10 in
response to pSAV compared to pcDNA3.3, but the differences were not significant. In general,
cytokines showed low upregulation in response to plasmids in the microarray analysis. RT-
qPCR analyses showed that CXCL10 and the proinflammatory cytokines IL-1ß and TNFα
were more strongly up-regulated by pSAV than by pcDNA3.3 (Fig 10). Up-regulation of
CXCL10 may be mediated by IFNγ as suggested by previous work [19]. Of cytokine receptors,
the microarray data showed higher up-regulation of IL2R and IL6R by pSAV than by
pcDNA3.3.
Discussion
A previous study showed that i.m. injection of Atlantic salmon with a plasmid expressing the
whole SAV3 structural polyprotein (here named pSAV) gave strong protection against
Fig 6. Microarray data showing expression of genes involved in MHC I antigen presentation. Data produced and
presented as explained in Fig 1.
https://doi.org/10.1371/journal.pone.0204924.g006
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development of pancreas disease caused by SAV3 infection accompanied by production of
IgM antibodies against the virus [6]. The present study was conducted to find out if transcrip-
tome analysis of muscle at the injection site might reveal a pattern of gene expression that
could shed light on the protective effect of the vaccine. DNA vaccination against a virus results
in uptake of plasmid and expression of virus protein both by muscle cells and resident APCs
[36]. Changes in immune gene expression at the muscle injection site might be due to innate
responses to plasmid DNA and to both innate and adaptive immune responses to the
expressed viral proteins. The transcriptome data in this work demonstrated that pSAV and
pcDNA3.3 had similar abilities to up-regulate typical IFN-I inducible genes (ISGs). The IFN-I
response to pSAV is thus likely to be a response to plasmid DNA rather than to the viral
Fig 7. Expression of genes involved in antigen presentation / phagocytosis in response to plasmids measured by
RT-qPCR. Treatment groups and sampling for RNA extraction as described in Fig 2. Expression value of each gene
was normalized against the levels of EF1αβ and fold increase in expression of different genes was calculated against
that of the PBS group. Bars not sharing common letter indicate significant difference (p 0.05).
https://doi.org/10.1371/journal.pone.0204924.g007
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proteins. The virus proteins expressed by pSAV do thus not seem to induce IFN-I such as the
G-protein of the DNA vaccine against IHNV [5, 8]. Moreover, pSAV does not inhibit the
IFN-I response unlike hemagglutininesterase in the DNA vaccine against ISAV [5, 8]. In fact,
pSAV induced a distinct set of genes in the muscle compared to the other two DNA vaccines.
Compared to pcDNA3.3, pSAV firstly caused higher up-regulation of IFNγ, which was sup-
ported by higher up-regulation of several IFNγ inducible genes. Secondly, pSAV caused larger
expression of marker genes for T-cells, B-cells and APCs, which might all be important for
development of the adaptive immune responses against the SAV3. Thirdly, pSAV caused a
stronger up-regulation of the chemokine CXCL10 and proinflammatory cytokines IL-1ß and
TNFα which may explain attraction of lymphocytes and APCs.
IFNγ response
One of the most prominent responses to pSAV was increased expression of IFNγ (Fig 2C) and
the IFNγ inducible genes IRF-1, GBP-1 and CXCL-10 (Figs 1, 2B and 9). This suggests that
expression of the SAV3 structural proteins results in increased IFNγ production at the muscle
injection site. IFNγ is regarded as a typical Th1 cytokine because it directs differentiation of
naïve CD4+ cells toward a Th1 phenotype and is a major product of CD4+ T helper 1 (Th1)
cells and CD8+ cytotoxic T cells [20]. Whether Th1 or cytotoxic T cells are the source of IFNγ
is, however, uncertain since 7 days post vaccination is very early in the development of an
adaptive immune response in cold water fish. More likely sources of IFNγ at this stage are nat-
ural killer (NK) cells, APCs and natural killer T (NKT) cells [20, 37]. Little is yet known about
NK and NKT cells in fish, however. Whichever source, enhanced production of IFNγ might
Fig 8. Microarray data showing expression of marker genes for antigen presenting cells (APC) / phagocytic cells. Data produced and
presented as explained in Fig 1.
https://doi.org/10.1371/journal.pone.0204924.g008
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Fig 9. Microarray data of chemokines, cytokines and their receptors. Data produced and presented as for Fig 1.
https://doi.org/10.1371/journal.pone.0204924.g009
Fig 10. Expression of chemokines and inflammatory cytokines in response to plasmids measured by RT-qPCR.
Treatment groups and sampling for RNA extraction as described in Fig 2. Expression value of each gene was
normalized against the levels of EF1αβ and fold change in expression of different genes was calculated against that of
the PBS group. Bars not sharing common letter indicate significant difference (p 0.05).
https://doi.org/10.1371/journal.pone.0204924.g010
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increase antigen presentation as discussed below, and thus influence the differentiation of T-
cells at the injection site.
Attraction of B- and T-cells
The data for pcDNA3.3 suggests that B-cells and T-cells are attracted to the plasmid injection
site by recognition of plasmid DNA by muscle cells as described in previous work [4]. Higher
mean transcript values for B-cell markers (IgM, IgD and IgT) were observed for the pSAV
group compared to pcDNA3.3, but the differences for the individual genes were not signifi-
cant. On the other hand, both the microarray and RT-qPCR analysis suggest increased attrac-
tion of T-cells to the pSAV injection site compared to pcDNA3.3, due to significantly
increased transcript levels of TCR chains, CD4, CD8 and CD3zeta. Attraction of cytotoxic T-
cells by pSAV is suggested by increased expression of CD8a and granzyme K. Taken together,
it is interesting to note that the T-cell response to pSAV appears to be more prominent than
the B-cell response. Whether cytotoxic T-cells are involved in the protective immune response
to SAV infection should thus be investigated in future studies.
APCs and genes involved in antigen presentation
Professional APCs include dendritic cells, macrophages and B-cells [26]. Participation of
APCs in initiation of the adaptive immune response against SAV3 structural proteins is sup-
ported by the fact that compared to pcDNA3.3, pSAV increased more strongly expression of
MHC II, CD74 and FcγRI (Figs 7 and 8). These molecules are constitutively expressed in pro-
fessional APCs, but may be up-regulated by IFNγ in professional and non-professional APCs
[20, 38]. pSAV may thus have a positive effect on antigen presentation through the MHC II
pathway.
In addition, pSAV gave higher transcript values for several genes that are involved in the
MHC I antigen presentation pathway (PSMB6, PSMB7, LMP-7, TAP1A, TAP2B and tapasin)
and which may be induced by IFNγ [20]. This suggests a more efficient presentation of virus
antigens through the MHC-I pathway possibly leading to cytotoxic T-cell production against
the virus. Notably, pSAV and pcDNA3.3 showed similar increases in MHC I heavy chain,
which suggests that MHC I expression is mainly triggered by plasmid DNA. MHC I is
expressed by most cells in mammals, but can be up-regulated by IFN-I and IFNγ [39, 40].
Taken together, pSAV appears to attract APCs and/or induce genes in resident APCs, which
provide a more efficient presentation of virus antigen to T-cells through both MHC pathways.
Chemokines and pro-inflammatory cytokines
Attraction of leukocytes to the plasmid injection site must be mediated by chemokines and/or
proinflammatory cytokines [35]. The RT-qPCR analyses suggest that CXCL10, IL-1ß and
TNFα, are likely to be involved in attraction of T-cells, B-cells and APCs since they are more
strongly up-regulated by pSAV than by pcDNA3.3. Up-regulation of CXCL10 may be medi-
ated by IFNγ as suggested by previous work [19]. IL-1ß and TNFα are key pro-inflammatory
cytokines [35, 41].
Conclusion
While previous work showed that vaccination of Atlantic salmon with pSAV leads to produc-
tion of antibodies against SAV, the present study suggests that pSAV vaccination also results
in a strong T-cell response due to attraction of T-cells, APCs and up-regulation of IFNγ.
Whether the antibody response to the SAV3 surface protein E2 is T-dependent or T-cell
Transcriptome analyses of salmon muscle injected with a DNA vaccine against salmonid alphavirus
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independent or whether cytotoxic T-cells are involved in protection against SAV3 is not
known. This study thus motivates future studies of cytotoxic T-cell responses to the DNA vac-
cine against SAV.
The data support the hypothesis that the muscle injection site is a meeting place for B-cells,
T-cells and APCs that is important for initiation of the adaptive immune response by the DNA
vaccine against SAV3. In mammals, activation of B- and T-cells might occur at the muscle
injection site, but plasmid transfected APCs also travel to lymph nodes for expression of anti-
gen and activation of B- and T -cells [36]. While fish do not possess lymph nodes, it cannot be
excluded that plasmid-transfected APCs travel to the head kidney and/or spleen for activation
of lymphocytes.
With these data, it can be concluded that the DNA vaccines against the viruses IHNV,
ISAV and SAV, each have unique transcript profiles at the muscle injection site 7 days after
vaccination. The G-protein vaccine against IHNV shows a strong IFN-I stimulatory profile
while the ISAV HE vaccine shows a profile of IFN-I inhibition [5, 8]. In contrast, the SAV3
vaccine shows neither positive nor negative effects on IFN-I induced genes while it shows a
clear IFNγ stimulatory profile.
Supporting information
S1 Fig. Microarray data showing expression of various leukocyte marker genes. Data pro-
duced and presented as explained in Fig 1.
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